Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction.

ABSTRACT: Despite an improvement in pharmacological therapies and mechanical reperfusion, the outcome of patients with acute myocardial infarction (AMI) is still suboptimal, especially in patients with cardiogenic shock (CS). The incidence of CS accounts for 3-15% of AMI cases, with mortality rates of 40% to 50%. In contrast to a large number of trials conducted in patients with AMI without CS, there is limited evidence-based scientific knowledge in the CS setting. Therefore, recommendations and actual treatments are often based on registry data. Similarly, knowledge of the available options in terms of temporary mechanical circulatory support (MCS) devices is not equally widespread, leading to an underutilisation or even overutilisation in different regions/countries of these treatment options and

SUBMITTER: De Luca L 

PROVIDER: S-EPMC10051785 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature